primary mediastinal B-cell lymphoma
GPTKB entity
Statements (53)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:healthcare_organization
|
| gptkbp:affects |
lymphatic system
|
| gptkbp:associated_with |
gptkb:NHL
gptkb:EBV HIV infection C D20 expression C D30 expression c-MYC rearrangement |
| gptkbp:can_lead_to |
lymphadenopathy
pleural effusion B-symptoms superior vena cava syndrome |
| gptkbp:first_described_by |
gptkb:1980s
|
| https://www.w3.org/2000/01/rdf-schema#label |
primary mediastinal B-cell lymphoma
|
| gptkbp:is_associated_with |
gptkb:healthcare_organization
thymoma other lymphomas mediastinal germ cell tumors |
| gptkbp:is_characterized_by |
large mediastinal mass
|
| gptkbp:is_often_used_in |
young adults
females males |
| gptkbp:is_used_for |
fatigue
weight loss fever night sweats |
| gptkbp:occurs_in |
rare
|
| gptkbp:research_focus |
gptkb:vaccine
biomarkers clinical trials treatment outcomes genetic profiling |
| gptkbp:risk_factor |
autoimmune diseases
genetic mutations |
| gptkbp:social_responsibility |
variable
imaging studies biopsy |
| gptkbp:symptoms |
cough
chest pain shortness of breath |
| gptkbp:treatment |
gptkb:vincristine
gptkb:cyclophosphamide gptkb:doxorubicin gptkb:rituximab gptkb:drug gptkb:prednisone radiation therapy chemotherapy stem cell transplant |
| gptkbp:type_of |
diffuse large B-cell lymphoma
|
| gptkbp:bfsParent |
gptkb:ALK
gptkb:large_B-cell_lymphoma |
| gptkbp:bfsLayer |
5
|